Show
Sort by
-
Importance and outcome relevance of central pathology review in prostatectomy specimens : data from the SAKK 09/10 randomized trial on prostate cancer
-
Re: Christopher JD Wallis, Refik Saskin, Richard Choo, et al. Surgery versus radiotherapy for clinically-localized prostate cancer : a systematic review and meta-analysis. Eur Urol 2016;70:21-30
-
Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey
-
- Journal Article
- A2
- open access
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
-
The oncologic role of local treatment in primary metastatic prostate cancer
-
Prognostic effect of neuroendocrine differentiation in prostate cancer : a critical review
-
Systematic ultrasound-guided saturation and template biopsy of the prostate : indications and advantages of extended sampling
-
- Journal Article
- A1
- open access
Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey
-
Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey
(2015) -
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series
-
Clinical perspectives from randomized phase 3 trials on prostate cancer : an analysis of the ClinicalTrials.gov database
-
Acute toxicity and early quality of life after dose intensified salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10
-
Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy : first results of the randomized trial SAKK 09/10
-
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer : results of the Quality Assurance Program of the Randomized Trial SAKK 09/10